Growth Metrics

bioAffinity Technologies (BIAF) Gross Profit (2022 - 2025)

bioAffinity Technologies has reported Gross Profit over the past 4 years, most recently at $692687.0 for Q4 2025.

  • Quarterly Gross Profit rose 7.32% to $692687.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, down 42.72% year-over-year, with the annual reading at $1.9 million for FY2025, 42.72% down from the prior year.
  • Gross Profit was $692687.0 for Q4 2025 at bioAffinity Technologies, up from $503855.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $989942.0 in Q2 2024 and troughed at $834.0 in Q1 2023.
  • The 4-year median for Gross Profit is $485737.0 (2025), against an average of $407310.5.
  • Year-over-year, Gross Profit skyrocketed 99774.1% in 2024 and then crashed 74.45% in 2025.
  • A 4-year view of Gross Profit shows it stood at $2171.0 in 2022, then skyrocketed by 25164.72% to $548497.0 in 2023, then rose by 17.67% to $645427.0 in 2024, then grew by 7.32% to $692687.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Gross Profit are $692687.0 (Q4 2025), $503855.0 (Q3 2025), and $252881.0 (Q2 2025).